Anlotinib combined with chemotherapy and immunotherapy for advanced pulmonary sarcomatoid cancer: A case report and literature review
Pulmonary sarcomatoid carcinoma (PSC) is a rare disease which is highly malignant with a poor prognosis. PSC is highly resistant to chemotherapy and radiotherapy and is prone to recurrence even after surgery. Most of what is known about PSC comes from limited single-center, retrospective studies. Th...
Saved in:
Main Authors: | Piao, Mei-Na, Ma, Xiao-Ting, Tankere, Pierre, Liam, Chong Kin, Li, Jin-Li, Wang, Jian-Ping |
---|---|
Format: | Article |
Published: |
Ame Publishing Company
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/40888/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What Lurks Beneath: Lacrimal Gland Adenocarcinoma Dedifferentiation to Sarcomatoid Carcinoma
by: Farrah-Hani Imran,, et al.
Published: (2015) -
Cancer immunotherapy: current progress and applications
by: Leong, Pooi Pooi, et al.
Published: (2006) -
Curcumin combination chemotherapy: the implication and efficacy in cancer
by: Tan, Bee Ling, et al.
Published: (2019) -
Dendritic cell immunobiology and potential roles in immunotherapy
by: Fadilah, S.A.W., et al.
Published: (2007) -
Therapeutic effect of local hyperthermia treatment combined with anti-CD200 immunotherapy in EMT6 breast cancer
by: Wan Mohd. Zawawi, Wan Fatin Amira
Published: (2021)